Chakraborty A.A. and Tansey W.P. (2009) Adenoviral E1A function through Myc. Cancer Res. 69(1):6-9.

Pelka P, Ablack J.N., Fonseca G.J., Yousef A.F. and Mymryk J.S. (2008) Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes. J Virol. 2008 Aug;82(15):7252-63.

Liao Y., Yu D. and Hung M.C. (2007) Novel approaches for chemosensitization of breast cancer cells: the E1A story. Adv Exp Med Biol. 608:144-69.

Higashimoto Y., Yamagata Y. and Itoh H.(2006) Complex effect of adenovirus early region proteins on innate immune system. Inflamm Allergy Drug Targets. 5:229-37.

Felsani A., Mileo A.M. and Paggi M.G.(2006) Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene. 25:5277-85.

Turnell A.S. and Mymryk J.S.(2006) Roles for the coactivators CBP and p300 and the APC/C E3 ubiquitin ligase in E1A-dependent cell transformation. Br J Cancer. 95:555-60.

Berk A.J. (2005) Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene. 24:7673-85.

Schaack J. (2005) Induction and inhibition of innate inflammatory responses by adenovirus early region proteins. Viral Immunol. 18:79-88.

Cook J.L. and Routes J.M. (2005) Adenovirus E1A gene-induced tumor cell rejection through cellular sensitization to immune and nonimmune apoptotic injuries. Front Biosci. 10:1396-414.

Williams J.F., Zhang Y., Williams M.A., Hou S., Kushner D. and Ricciardi R.P. (2004) E1A-based determinants of oncogenicity in human adenovirus groups A and C. Curr Top Microbiol Immunol. 273:245-88.

Endter C. and Dobner T. (2004) Cell transformation by human adenoviruses. Curr Top Microbiol Immunol. 273:163-214.

Chinnadurai G. (2004) Modulation of oncogenic transformation by the human adenovirus E1A C-terminal region. Curr Top Microbiol Immunol. 273:139-61.

Blair G.E. and Blair-Zajdel M.E. (2004) Evasion of the immune system by adenoviruses. Curr Top Microbiol Immunol. 273:3-28.

Lavia P., Mileo A.M., Giordano A. and Paggi M.G. (2003) Emerging roles of DNA tumor viruses in cell proliferation: new insights into genomic instability. Oncogene. 22:6508-16.

Padmanabhan R., Tanimoto A. and Sasaguri Y. (2003) Transactivation of human cdc2 promoter by adenovirus E1A. Curr Top Microbiol Immunol. 272:365-97.

Akusjärvi G. and Stévenin J. (2003) Remodelling of the host cell RNA splicing machinery during an adenovirus infection. Curr Top Microbiol Immunol. 272:253-86.

Helt A.M. and Galloway D.A. (2003) Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis. 24:159-69.

Frisch S.M. and Mymryk J.S. (2002) Adenovirus-5 E1A: paradox and paradigm. Nat Rev Mol Cell Biol 3, 441-52.

Ben-Israel H. and Kleinberger T. (2002) Adenovirus and cell cycle control. Front Biosci 7, D1369-95.

Sang N., Caro J. and Giordano A. (2002). Adenoviral E1A: everlasting tool, versatile applications, continuous contributions and new hypotheses. Front Biosci. 7, D407-13.

Gallimore, P.H. and Turnell, A.S. (2001). Adenovirus E1A: remodelling the host cell, a life or death experience. Oncogene 20, 7824-35.

White E. (2001). Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus.Oncogene 20, 7836-46.

Frisch S.M. (2001). Tumor suppression activity of adenovirus E1a protein: anoikis and the epithelial phenotype. Adv Cancer Res. 80, 39-49.

Breckenridge, D.G. and Shore G.C. (2000). Regulation of apoptosis by E1A and Myc oncoproteins.Crit Rev Eukaryot Gene Expr.10, 273-80.

Berk A.J., Boyer T.G., Kapanidis A.N., Ebright R.H., Kobayashi N.N., Horn P.J., Sullivan S.M., Koop R., Surby M.A. and Triezenberg SJ. (1998). Mechanisms of viral activators. Cold Spring Harb Symp Quant Biol. 63, 243-52.

Yu D. and Hung M.C. (1998). The erbB2 gene as a cancer therapeutic target and the tumor- and metastasis-suppressing function of E1A. Cancer Metastasis Rev. 17, 195-202.

Flint, J. and Shenk, T. (1997). Viral transactivating proteins. Annual Rev. Genet. 31, 177-212.

Mymryk, J.S. and Smith, M.M. (1997). Influence of the adenovirus 5 E1A oncogene on chromatin remodelling. Biochem. Cell Biol. 75, 95-101.

Mymryk, J.S. (1996). Tumour suppressive properties of the adenovirus 5 E1A oncogene. Oncogene 13, 1581-1589.

Frisch, S.M. (1996). Reversal of malignancy by the adenovirus E1a gene. Mutations Research-Fundamental and Molecular Mechanisms of Mutagenesis 350, 261-266.

Hagmeyer, B.M., Angel, P. and van Dam, H. (1995). Modulation of AP-1/ATF transcription factor activity by the adenovirus-E1A oncogene products. Bioessays 17, 621-629.

Jones, N. (1995). Transcriptional modulation by the adenovirus E1A gene. Curr. Top. Microbiol. Immunol. 199, 59-80.

Ludlow, J.W. and Skuse, G.R. (1995). Viral oncoprotein binding to pRB, p107, p130, and p300. Virus Res 35, 113-121.

Nevins, J.R. (1995). Adenovirus E1A: transcription regulation and alteration of cell growth control. Curr. Top. Microbiol. Immunol. 199, 25-32.

Raska, K. Jr. (1995). Functional domains of adenovirus E1A oncogenes which control interactions with effectors of cellular immunity. Curr. Top. Microbiol. Immunol. 199, 131-148.

White, E. (1995). Regulation of p53-dependent apoptosis by E1A and E1B. Curr. Top. Microbiol. Immunol. 199, 34-58.

Williams, J., Williams, M., Liu, C., and Telling, G. (1995). Assessing the role of E1A in the differential oncogenicity of group A and group C human adenoviruses. Curr. Top. Microbiol. Immunol. 199, 149-175.

Yoshida, K., Higashino, F., and Fujinaga, K. (1995). Transcriptional regulation of the adenovirus E1A gene. Curr. Top. Microbiol. Immunol. 199, 113-130.

Bayley, S.T. and Mymryk, J.S. (1994). Adenovirus E1A proteins and transformation (Review). Int. J. Oncology 5, 425-444.

Moran, E. (1994) Cell growth control mechanisms reflected through protein interactions with the adenovirus E1A gene products. Semin. Virol. 5, 327-340.

Akusjarvi, G. (1993). Proteins with transcription regulatory properties encoded by human adenoviruses. Trends. Microbiol. 1, 163-170.

Peeper, D.S. and Zantema, A. (1993). Adenovirus-E1A proteins transform cells by sequestering regulatory proteins. Mol. Biol. Rep. 17, 197-207.

White, E. (1993). Regulation of apoptosis by the transforming genes of the DNA tumor virus adenovirus. Proc. Soc. Exp. Biol. Med. 204, 30-39.

Berk, J.A. (1992). Adenovirus E1A trans-activation: understanding it will require learning how the general transcription factors function. In Transcriptional Regulation. S.L. McKnight and K.R. Yamamoto, eds. (Plainsville, New York: Cold Spring Harbor Laboratory Press), pp. 727-742.

Chinnadurai, G. (1992). Adenovirus E1a as a tumor-suppressor gene. Oncogene 7, 1255-1258.

Dyson, N. and Harlow, E. (1992). Adenovirus E1A targets key regulators of cell proliferation. Cancer Surv. 12, 161-195.

Jones, N.C. (1992). The multifunctional products of the adenovirus E1A gene. In Malignant transformation by DNA tumor viruses. W. Doerfler and P. Bohm, eds. (New York NY: VCH Publishers), pp. 87-113.

Martin, K.J. and Green, M.R. (1992). Transcriptional activation by viral immediate-early proteins: variations on a common theme. In Transcriptional regulation. S.L. McKnight and K.R. Yamamoto, eds. (Plainview, NY: Cold Spring Harbor Laboratory Press), pp. 695-725.

Boulanger, P.A. and Blair, G.E. (1991). Expression and interactions of human adenovirus oncoproteins. Biochem. J. 275, 281-299.

Braithwaite, A.W., Nelson, C.C., and Bellet, A.J. (1991). E1a revisited: the case for multiple cooperative trans-activation domains. New Biol. 3, 18-26.

Shenk, T. and Flint, J. (1991). Transcriptional and transforming activities of the adenovirus E1A proteins. Adv. Cancer Res. 57, 47-85.

Nevins, J.R. (1989). Mechanisms of viral-mediated trans-activation of transcription. Adv. Virus Res 37, 35-83.

Grand, R.J. (1987). The structure and functions of the adenovirus early region 1 proteins. Biochem. J. 241, 25-38.

Moran, E. and Mathews, M.B. (1987). Multiple functional domains in the adenovirus E1A gene. Cell 48, 177-178.

Berk, A.J. (1986). Functions of adenovirus E1A. Cancer Surv. 5, 367-387.

Branton, P.E., Bayley, S.T., and Graham, F.L. (1985). Transformation by human adenoviruses. Biochim. Biophys. Acta 780, 67-94.